News | Artificial Intelligence | February 27, 2024

At ECR23, Median will unveil the latest developments for eyonis alongside its AI-powered clinical trial imaging services

At ECR23, Median will unveil the latest developments for eyonis alongside its AI-powered clinical trial imaging services

February 27, 2024 — Median Technologies announced that the Company will be participating and speaking at the premier European radiology conference, the European Congress of Radiology (ECR), being held in Vienna, Austria, February 28 – March 3, 2024.

Presentation at the AI Theater Industry Sessions/AI Lightning Talks 2 (AI exhibition, Expo X1)
February 28 at 12:30 pm CET: “Eyonis LCS: Revealing Independent Verification Results & Advancements in Clinical Validation Studies”, presented by Anne Chibois, eyonis Clinical Science Director, Median Technologies, and Benoit Huet, eyonis AI and Data Science Director, Median Technologies.

Presentation at the AI Theater Industry Sessions/AI Lightning Talks 5 (AI exhibition, Expo X1)
February 29 at 12:50 pm CET: “eyonis AI tech-based CADe/CADx device suite: unveiling independent verification results in Lung Cancer Screening & preliminary Hepatocellular carcinoma diagnosis results”, presented by Pr. Philippe Grenier, Thoracic Radiologist and Head of the Artificial Intelligence project, Foch Hospital, Saint Cloud, France and Pr. Olivier Lucidarme, Head of Radiology Department, La Pitié-Salpêtrière Hospital, AP-HP, Sorbonne University, Paris, France.

 

Scientific poster

“Developing a novel computer-aided diagnostic technique based on deep learning and CT images for early HCC diagnosis”, O. Lucidarme, V. Paradis, C. Guettier, I. Brocheriou, J. Shen, S. Poullot , V. K. LE, V. Vilgrain , M. Lewin Zeitoun. Link available soon: EPOS™ website.

Median’s eyonis and iCRO/Imaging Lab teams will be available at booth #AI-17, AI Exhibition, Expo X1 for the duration of the industry exhibition (February 28 – March 2, 10:00 am – 5:00 pm CET).

For more information: www.mediantechnologies.com

 

Find more ECR24 conference coverage here


Related Content

News | FDA

April 16, 2026 — Royal Philips has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral ...

Time April 20, 2026
arrow
News | Radiology Imaging

April 7, 2026 — Onvida Health and Siemens Healthineers have entered a 10-year Value Partnership¹ designed to bring the ...

Time April 09, 2026
arrow
News | Computed Tomography (CT)

April 2, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for True ...

Time April 03, 2026
arrow
News | Ultrasound Imaging

March 30, 2026 — Butterfly Network, Inc. has received clearance from the U.S. Food and Drug Administration (FDA) for a ...

Time April 01, 2026
arrow
News | Computed Tomography (CT)

March 30, 2026 — HCA Healthcare’s Good Samaritan Hospital is the first hospital in the Bay Area to implement Lumina 3D ...

Time April 01, 2026
arrow
News | Radiology Business

March 31, 2026 — Radon Medical Imaging, a medical imaging equipment maintenance and repair services company, has has ...

Time March 31, 2026
arrow
News | Radiology Imaging

March 26, 2026 — GE HealthCare has announced a renewed research collaboration with Stanford Medicine Department of ...

Time March 30, 2026
arrow
News | Cardiac Imaging

March 28, 2026 — When Ashley Perlow felt a sharp pain shoot across her chest and into both wrists, she didn't think it ...

Time March 30, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

March 25, 2026 A Penn Medicine–led team has developed a first‑of‑its‑kind artificial intelligence system that interprets ...

Time March 26, 2026
arrow
News | FDA

March 24, 2026 — MARS Bioimaging, a New Zealand–headquartered medical device company, has received U.S. Food and Drug ...

Time March 25, 2026
arrow
Subscribe Now